REGADENOSON FOR PHARMACOLOGICAL STRESS TESTS - BLOOD PRESSURE, HEART RATE, AND MAJOR SIDE EFFECTS IN 5780 PATIENTS REFERRED FOR MYOCARDIAL SCINTIGRAPHY: A HIGH-VOLUME SINGLE-CENTER EXPERIENCE

2019 
Regadenoson is a highly selective A2A receptor agonist and approved in many countries for myocardial perfusion pharmacological SPECT stress imaging. As a vasoactive drug, Regadenoson does have side effects, but there is only data regarding this issue available from some smaller studies, no
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []